In many cancers, including lung carcinoma, the PI3K/AKT/mTOR pathway is hyperactive, thus blocking apoptosis through the regulation of downstream signaling molecules, such as inhibiting the activation of Caspase-7, as well inactivating Bcl-2 family members [50,51]. Here, BCL2 is linked to cancer.